The leadership challenges of a high-growth tech company vs. a company undergoing transformation are vastly different. Transformation requires confronting ambiguity and building new organizational connections, not just managing independent teams and product lines.
🔬 Latest pharma updates 👇 Gilead buys Interius for $350M, Vanda wins FDA case, Merck KGaA partners Skyhawk, Novo Nordisk's Wegovy label expands, Kriya raises $313M, CSL to spin off Seqirus, Soligenix gets FDA nod, Stealth resubmits, Genentech ends $2B Adaptive deal, PTC's drug rejected, REGENXBIO delayed, Viking weight-loss pill struggles, Opthea cuts 85%, EU approves Madrigal's NASH drug, Tharimmune surges, Rocket Pharma lifted, Ionis' new HAE drug. Novo Nordisk freezes hiring, Merck's desmoid tumor drug approved, Biohaven committee cancelled.
1/ Biologists fail at computation not because it's hard, but they start in the wrong place. Here's a roadmap. 2/ Bioinformatics is computation. Master the tools, master the science. Start simple, go deep. Resources to save you. 3/ Linux & command line are essential. Can't script? You're blind. Software Carpentry, Linux Works, Data Science at the Command Line. 4/ R for Data Science, Tidyverse, reshaping data. Data Analysis for Life Sciences with R. 5/ Advanced stats & genomics, linear algebra & ML, Python - a survival guide for bioinformatics.
Shocking: Adults consume ~250g microplastics/year, equivalent to a credit card. Microplastics cross blood-brain barrier, linked to chronic disease. Routes include diet, inhalation, skin contact. Urgent need for action to reduce microplastic pollution. #health #science
Nonprofits face financial stress, with 73% of EDs citing reporting as a top concern. But the real crisis is survival, as 50% have <3 months cash reserves. A new Nonprofit Financial Resource Center offers tools, templates, and expert guidance to build financial resilience and protect missions.